Introducing the new Spruson & Ferguson brand
Today, Spruson & Ferguson is proud to unveil our new brand. Our new brand builds on our position as a market leader in intellectual property services, and defines what will...
Today, Spruson & Ferguson is proud to unveil our new brand. Our new brand builds on our position as a...
Read More
Skinny labelling in the Australian context: an overview
This article was first published in the 2023 Pharmaceutical Patent Review. Key takeaways In Australia, new indications for known pharmaceuticals may be protected by several different patent claim formats, including method of...
This article was first published in the 2023 Pharmaceutical Patent Review. Key takeaways In Australia, new indications for known pharmaceuticals may be...
Read More
IAM Patent 1000 2024
Spruson & Ferguson has once again been recognised in the 2024 IAM Patent 1000 rankings across the Asia-Pacific, with an outstanding result in multiple countries. We are delighted to announce the...
Spruson & Ferguson has once again been recognised in the 2024 IAM Patent 1000 rankings across the Asia-Pacific, with an outstanding...
Read More
Pharmaceutical patent term extension in Australia
This article was first published in the 2023 Pharmaceutical Patent Review. Patent term extensions (PTEs) can be of great commercial importance, and in recent years have become of particular interest...
This article was first published in the 2023 Pharmaceutical Patent Review. Patent term extensions (PTEs) can be of great commercial...
Read More
China joins Patent Prosecution Highway Improvement Initiative
The China National Intellectual Property Administration (CNIPA) has announced its participation in the "PPH Improvement Initiative", which aims to improve the user experience of the Patent Prosecution Highway (PPH).  This...
The China National Intellectual Property Administration (CNIPA) has announced its participation in the "PPH Improvement Initiative", which aims to...
Read More
Protecting your brand from counterfeits
In January 2024, the EU Intellectual Property Office (EUIPO) released a robust study to assess the economic impact of counterfeiting in sales and employment in the clothing (including footwear),...
In January 2024, the EU Intellectual Property Office (EUIPO) released a robust study to assess the economic impact of...
Read More
IP Australia releases 2024 Intellectual Property Report
IP Australia has released the twelfth edition of the Australian Intellectual Property Report 2024 (the Report) which presents key movements in IP statistics and explores the links between innovation,...
IP Australia has released the twelfth edition of the Australian Intellectual Property Report 2024 (the Report) which presents key...
Read More
Navigating the waves of greenwashing | “Green” trade mark regulations in China
In China, there are different regulatory practices concerning "green" trade marks. Regarding the registration process, it has been observed that the China National Intellectual Property Administration (CNIPA) has adopted...
In China, there are different regulatory practices concerning "green" trade marks. Regarding the registration process, it has been observed...
Read More
Navigating the Waves of Greenwashing | Implications for trade mark owners
In the current global landscape, environmental awareness has become a pivotal aspect of consumer decision-making, with many brands eager to market their sustainability credentials. While for some brands this...
In the current global landscape, environmental awareness has become a pivotal aspect of consumer decision-making, with many brands eager...
Read More
Federal Budget 24-25 “Future Made in Australia” features for cleantech
Treasurer Jim Chalmers delivered his third Federal Budget on Tuesday, 14 May 2024, featuring the promised details and costings of the recently announced Future Made in Australia Act, and...
Treasurer Jim Chalmers delivered his third Federal Budget on Tuesday, 14 May 2024, featuring the promised details and costings...
Read More
Infringement of second medical use claims | Federal Court decision adds guidance
In pharmaceutical patent litigation, issues concerning infringement of method of treatment and Swiss-style claims covering new indications for known substances arise frequently. In this article, we discuss the recent...
In pharmaceutical patent litigation, issues concerning infringement of method of treatment and Swiss-style claims covering new indications for known...
Read More
Future made in Australia Act | A shot in the arm for cleantech?
The recently announced Future Made in Australia Act may turn out to be the shot in the arm the Australian cleantech sector has been waiting for… Cleantech, IP and Australia We’ve...
The recently announced Future Made in Australia Act may turn out to be the shot in the arm the...
Read More

Contact our Expert Team

Contact Us
Contact Us